@article{40c16e4472fe4352802cd2bde2ab6659,
title = "Haemodialysis in Samoa: A model for other Pacific nations",
keywords = "Chronic kidney disease, Diabetes mellitus, End-stage kidney disease, Haemodialysis, Oceania, Pacific Islands, Samoa",
author = "Nia Aitaoto and Raphael, {Kalani L.}",
note = "Funding Information: Most information regarding haemodialysis outcomes are from developed countries. Very little is known about the provision of haemodialysis and long-term outcomes in middle-income countries, particularly in the Pacific. In The Lancet Regional Health – Western Pacific, Tafuna'i and colleagues describe the establishment of a chronic haemodialysis program in the independent nation of Samoa (total population 202 000) and the incidence and prevalence of ESKD there [6] . Before the dialysis program was established, 5% of the Samoan health budget (USD 1•3 million) was used to dialyze 6 patients in New Zealand, prompting a change in how ESKD-care was provided to its citizens. Financial support from the Singapore National Kidney Foundation helped establish a haemodialysis program in Samoa operated by the National Kidney Foundation of Samoa (NKFS). NKFS is now largely funded by the Samoan government, though patients pay USD 3•70 per treatment. Funding Information: KLR is supported by US Department of Veterans Affairs Clinical Sciences Research and Development Service Merit Award I01CX001695.",
year = "2021",
month = jan,
doi = "10.1016/j.lanwpc.2020.100071",
language = "English (US)",
volume = "6",
journal = "The Lancet Regional Health - Western Pacific",
issn = "2666-6065",
publisher = "Elsevier Ltd",
}